MarketPulse
I

$IONS

3 articles found
2 positive
0 negative
1 neutral
Investing.comInvesting.com··Thomas Hughes

Insider Selling as a Contrarian Signal: Why $WM and $IONS Merit Investor Attention

Insider selling at $WM and $IONS masks attractive opportunities as institutional accumulation and strong fundamentals validate contrarian bullish cases for both stocks.
WMIONSdividend growthprofit-taking
The Motley FoolThe Motley Fool··Jonathan Ponciano

Boone Capital Exits 372% Biotech Winner to Chase Emerging Clinical Plays

Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.
MDTTYRAIONSCOGTBMRN+2biotechclinical-stage
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

ALS Therapeutics Market Poised to More Than Double by 2035

ALS therapeutics market to more than double by 2035, reaching $1.96 billion. Growth driven by genetic therapies, improved diagnostics, and disease awareness.
CYTKBIIBIONSAMLXrare diseasegene therapy